<scp>IL23</scp> Receptor Polymorphism Is a Predictor of Anti‐Tumour Necrosis Factor‐α‐Induced Paradoxical Psoriasis in Inflammatory Bowel Disease
Variation in the IL23R gene may identify those at risk of anti-TNFα-induced PP, beyond clinical variables. Further validation of this finding may promote its utility as a clinically actionable tool for the safe delivery of IBD medical therapy.
Authors
- Richard B. Kim (ORCID: https://orcid.org/0000-0001-8148-1632)
- M Gindi
- Navneet Natt (ORCID: https://orcid.org/0000-0002-9465-7534)
- Reena Khanna (ORCID: https://orcid.org/0000-0002-8679-2541)
- Aze Wilson (ORCID: https://orcid.org/0000-0001-6568-1714)
- Michael Sey (ORCID: https://orcid.org/0000-0002-0337-2366)
- Terry Ponich
- Nilesh Chande
- James C. Gregor
- Gio Randon Dela Cruz
- Keith McIntosh
- Melanie Beaton
Institutions
- Western University (CA)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1111/apt.70377
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Academic Medical Organization of Southwestern Ontario